We are pleased to note that our AIM listed direct investment Concepta PLC ("Concepta") has today announced important news regarding the first pregnancies from early adopters of myLotus®, its home fertility testing and pregnancy tracking device. The confirmation of first pregnancies is validation that the women's fertility monitor, myLotus®, is able to successfully enhance fertility, by helping women to personally monitor their hormone cycles and ovulation profiles to find their most fertile days to conceive naturally.
Launched in November 2018, Concepta's myLotus® has already made significant commercial progress securing a commercial partnership with Walgreens Boots Alliance in March 2019, launching an eCommerce website and listing myLotus® on Amazon. Concepta continues to seek out further collaborative opportunities with large diagnostic and retail pharmacy groups, in addition to hospital and IVF fertility clinics to advance myLotus® success.
Mercia holds a 22.4% direct equity stake in Concepta, having worked with the company via its managed funds before making its first balance sheet investment in May 2016.
Peter Dines, Chief Operating Officer at Mercia and a non-executive director of Concepta, said: "These first pregnancies and strong testimonials from myLotus® users are hugely exciting. Concepta has made significant commercial progress since launching six months ago and we look forward to further collaborative partnerships increasing the availability of myLotus® across the UK and overseas."